Comparative efficacy and safety of immunotherapy in the first-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis
Zheran Liu(Sichuan University), Xingchen Peng(Sichuan University), Ruidan Li(Sichuan University), Xiaolin Hu(Southwest Hospital), Ye Chen(Sichuan University), Jingjing Wang(State Key Laboratory of Biotherapy), Yan He(Sichuan University), Ling He(Sichuan University), Zhigong Wei(North Sichuan Medical University), Xiaoli Mu(Sichuan University)
Cited by 8
Related Papers
Targeting mitochondria by lipid-selenium conjugate drug results in malate/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression
|International Journal of Biological Sciences|2024|115
Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease
|Cardiovascular Diabetology|2024|72
Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk
|Frontiers in Immunology|2023|40
Survival outcomes following treatment delays among patients with early-stage female cancers: a nationwide study
|Journal of Translational Medicine|2022|32
Prognostic nomogram for adenoid cystic carcinoma in different anatomic sites
|Head & Neck|2020|29